Natural products from marine origin constitute a very promising and underexplored source of interesting compounds for modern biotechnological and pharmaceutical industries. However, their evaluation is quite challenging and requires specifically designed assays to reliably identify the compounds of interest in a highly heterogeneous and interfering context. In the present study, we describe a general strategy for the confident identification of tight-binding protease inhibitors in the aqueous extracts of 62 Cuban marine invertebrates, using hemoglobinases Plasmepsin II and Falcipain 2 as model enzymes. To this end, we first developed a screening strategy that combined enzymatic with interaction-based assays and then validated screening conditions using five reference extracts. Interferences were evaluated and minimized. The results from the massive screening of such extracts, the validation of several hits by a variety of interaction-based assays and the purification and functional characterization of PhPI, a multifunctional and reversible tight-binding inhibitor for Plasmepsin II and Falcipain 2 from the gorgonian , are presented.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408269PMC
http://dx.doi.org/10.3390/md15040123DOI Listing

Publication Analysis

Top Keywords

plasmepsin falcipain
12
interaction-based assays
12
identification tight-binding
8
inhibitors aqueous
8
aqueous extracts
8
marine invertebrates
8
enzymatic interaction-based
8
tight-binding plasmepsin
4
falcipain inhibitors
4
extracts
4

Similar Publications

Advances in protease inhibition-based chemotherapy: A decade of insights from Malaria research.

Adv Parasitol

October 2024

Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic.

Article Synopsis
  • Recent research on the parasite Plasmodium falciparum has advanced our understanding of protease isoenzymes, revealing their unique roles and biochemical features.
  • *The findings have led to new chemotherapy options that utilize low molecular weight inhibitors to target specific molecular sites within the parasite.
  • *Additionally, advancements in proteasome inhibition and research on vital metalloproteases are paving the way for the potential treatment and study of other lesser-known parasitic diseases.*
View Article and Find Full Text PDF

Purpose: The resistance of parasite to readily affordable antimalarial drugs, the high cost of currently potent drugs, and the resistance of vector mosquitoes to insecticides threaten the possibility of malaria eradication in malaria endemic areas. Due to the fact that quinine and artemisinin were isolated from plants sources, researchers have been encouraged to search for new antimalarials from medicinal plants. This is especially the case in Africa where a large percentage of the population depends on medicinal plant to treat malaria and other ailments.

View Article and Find Full Text PDF

A key element of Plasmodium biology and pathogenesis is the trafficking of ~10% of the parasite proteome into the host red blood cell (RBC) it infects. To cross the parasite-encasing parasitophorous vacuole membrane, exported proteins utilise a channel-forming protein complex termed the Plasmodium translocon of exported proteins (PTEX). PTEX is obligatory for parasite survival, both in vitro and in vivo, suggesting that at least some exported proteins have essential metabolic functions.

View Article and Find Full Text PDF

Background: The search for new antimalarial drugs remains elusive prompting research into antimalarial combinations from medicinal plants due to their cheapness, efficacy and availability. Azadirachta indica (AI), Morinda lucida (ML) and Mangifera indica (MI) have all been reported as potent antimalarial plants.

Purpose: This study evaluated the efficacy of an antimalarial combination therapeutics prepared from leaves of AI, ML and MI using in vitro, in vivo and molecular methods.

View Article and Find Full Text PDF

Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.

Int J Parasitol Drugs Drug Resist

August 2021

Department of Internal Medicine, University of South Florida, Tampa, FL, 33612, USA. Electronic address:

Emergence and spread of resistance in Plasmodium falciparum to the frontline treatment artemisinin-based combination therapies (ACTs) in the epicenter of multidrug resistance of Southeast Asia threaten global malaria control and elimination. Artemisinin (ART) resistance (or tolerance) is defined clinically as delayed parasite clearance after treatment with an ART drug. The resistance phenotype is restricted to the early ring stage and can be measured in vitro using a ring-stage survival assay.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!